4//SEC Filing
O'Neill Gilmore Neil 4
Accession 0001650664-24-000076
CIK 0001650664other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:17 PM ET
Size
5.0 KB
Accession
0001650664-24-000076
Insider Transaction Report
Form 4
O'Neill Gilmore Neil
DirectorCEO
Transactions
- Sale
Common Stock
2024-06-04$5.50/sh−12,191$66,997→ 315,279 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 13, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2024. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001742084
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:17 PM ET
- Size
- 5.0 KB